Considering orexin essentially as a neurotransmitter inhibiting REM sleep and, to a much lesser extent, a wake promoting agent, also fits with the objective observations reported about sleep in patients with narcolepsy type 1 in whom a deficit in orexin represents the main biological hallmark. Here, HCRT is linked to narcolepsy-cataplexy syndrome.